[vc_row type=”in_container” scene_position=”center” text_color=”dark” text_align=”left” overlay_strength=”0.3″][vc_column column_padding=”no-extra-padding” column_padding_position=”all” background_color_opacity=”1″ background_hover_color_opacity=”1″ width=”1/1″][vc_column_text]Robert M. Califf, M.D. the newly appointed commissioner of the Food and Drug Administration, calls the opportunity a “rare and humbling one in his recent blog, “Priorities.” Califf said that he wants to “make a positive difference at an institution that does vitally important work for the nation and its citizens.” He lists his priorities in this blog, deeming them critical to his success, and regulation of e-cigarettes was mentioned in the blog, albeit briefly. He called this priority a critical issue that was on his front burner for the foreseeable future.

He wrote:

“Tobacco product deeming. Much effort has gone into developing the framework for the approach to the regulation of the broad array of tobacco products. FDA is working hard to finalize the deeming rule, which in its proposed form would extend FDA regulation over virtually all tobacco products, including electronic cigarettes, either all cigars or all but premium cigars, pipe tobacco, certain dissolvables that are not “smokeless tobacco,” gels, and waterpipe tobacco.”

For Califf’s full blog, visit http://blogs.fda.gov/fdavoice/index.php/2016/03/priorities-teamwork-to-achieve-common-goals.[/vc_column_text][/vc_column][/vc_row]